{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:06:01Z","timestamp":1790258761338,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.ejpb.2008.09.001","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T12:17:05Z","timestamp":1221740225000},"page":"271-281","source":"Crossref","is-referenced-by-count":27,"title":["Intraorally fast-dissolving particles of a poorly soluble drug: Preparation and in vitro characterization"],"prefix":"10.1016","volume":"71","author":[{"given":"Riikka","family":"Laitinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Suihko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisa","family":"Toukola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Bj\u00f6rkqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Riikonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa Pekka","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina","family":"J\u00e4rvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarkko","family":"Ketolainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2008.09.001_bib1","series-title":"Modified-release Drug Delivery Technology","first-page":"349","article-title":"Oral mucosal drug delivery","author":"Kellaway","year":"2002"},{"key":"10.1016\/j.ejpb.2008.09.001_bib2","first-page":"44","article-title":"Fast-melting tablets: developments and technologies","volume":"2","author":"Dobetti","year":"2001","journal-title":"Phar. Tech. Feb."},{"key":"10.1016\/j.ejpb.2008.09.001_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejps.2003.07.002","article-title":"In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance","volume":"20","author":"Bredenberg","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2008.09.001_bib4","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/jps.10163","article-title":"Development and in vivo evaluation of buccal tablets prepared using danazol-sulfobutylether 7 \u03b2-cyclodextrin (SBE 7) complexes","volume":"91","author":"Jain","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2008.09.001_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","article-title":"Improving drug solubility for oral delivery using solid dispersions","volume":"50","author":"Leuner","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i23.40","article-title":"Solid dispersions: revival with greater possibilities and applications in oral drug delivery","volume":"20","author":"Sethia","year":"2003","journal-title":"Crit. Rev. Therap. Drug. Carrier Syst."},{"key":"10.1016\/j.ejpb.2008.09.001_bib7","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/jps.2600600902","article-title":"Pharmaceutical applications of solid dispersion systems","volume":"60","author":"Chiou","year":"1971","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2008.09.001_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0378-5173(01)00801-8","article-title":"Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis","volume":"226","author":"Forster","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib9","first-page":"103","article-title":"Effect of hydrogen bonding interactions on the release of felodipine from nanodispersions with polyvinylpyrrolidone","volume":"63","author":"Karavas","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2008.09.001_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.2042-7158.1997.tb06812.x","article-title":"Physical stability of solid dispersions containing triamterene or temazepam in polyethylene glycols","volume":"49","author":"Dordunoo","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2008.09.001_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5173(02)00532-X","article-title":"Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 600 solid dispersions","volume":"249","author":"Verheyen","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2007.03.037","article-title":"Combining SEM, TEM and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix","volume":"340","author":"Karavas","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib13","series-title":"Characterization and properties of nanomaterials","first-page":"333","year":"2004"},{"key":"10.1016\/j.ejpb.2008.09.001_bib14","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1002\/jps.20697","article-title":"Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine","volume":"95","author":"Konno","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2008.09.001_bib15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/jps.1054","article-title":"Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 Solid dispersions","volume":"90","author":"Law","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2008.09.001_bib16","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1023\/A:1012167410376","article-title":"Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions","volume":"14","author":"Taylor","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2008.09.001_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0031-6865(94)00051-V","article-title":"The properties of solid dispersions of clofibate in polyethylene glycols","volume":"70","author":"Anguiano-Igea","year":"1995","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.ejpb.2008.09.001_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2004.08.005","article-title":"Solid dispersions of nimodipine, polyethylene glycol 2000 Dissolution properties and physico-chemical characterization","volume":"59","author":"Urbanetz","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejpb.2004.05.011","article-title":"Study of the physicochemical properties, stability of solid dispersions of loperamide, PEG 6000 Prepared by spray drying","volume":"59","author":"Weuts","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib20","series-title":"Clarke\u2019s Analysis of Drugs and Poisons","year":"2006"},{"key":"10.1016\/j.ejpb.2008.09.001_bib21","series-title":"Cohesive properties and solubility parameter concepts","first-page":"287","year":"1999"},{"key":"10.1016\/j.ejpb.2008.09.001_bib22","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1021\/js9900856","article-title":"Solubility parameters as predictors of miscibility in solid dispersions","volume":"88","author":"Greenhalg","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2008.09.001_bib23","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s11095-006-9063-9","article-title":"Theoretical and practical approaches for prediction of drug\u2013polymer miscibility and solubility","volume":"23","author":"Marsac","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2008.09.001_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(96)04828-4","article-title":"The use of solubility parameters in pharmaceutical dosage form design","volume":"148","author":"Hancock","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib25","series-title":"Cohesive properties and solubility","first-page":"189","year":"1997"},{"key":"10.1016\/j.ejpb.2008.09.001_bib26","first-page":"83","volume":"225","author":"Nair","year":"2001","journal-title":"Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation"},{"key":"10.1016\/j.ejpb.2008.09.001_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(02)00647-6","article-title":"Investigations on the predictability of the formation of glassy solid solutions of drugs in sugar alcohols","volume":"252","author":"Langer","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/03639040500214621","article-title":"Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants","volume":"31","author":"Mura","year":"2005","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2003.11.025","article-title":"Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods","volume":"272","author":"Sethia","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jpba.2005.01.030","article-title":"Improving the solubility of ampelopsin by solid dispersions and inclusion complexes","volume":"38","author":"Ruan","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2008.09.001_bib31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.matsci.30.1.545","article-title":"Synthesis and characterization of monodisperse nanocrystals and close-packed nanocrystal assemblies","volume":"30","author":"Murray","year":"2000","journal-title":"Annu. Rev. Mater. Sci."},{"key":"10.1016\/j.ejpb.2008.09.001_bib32","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1021\/la0624283","article-title":"Formation of silica nanoparticles in microemulsions","volume":"23","author":"Finnie","year":"2007","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2008.09.001_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-5173(01)00891-2","article-title":"The mechanisms of drug release from solid dispersions in water-soluble polymers","volume":"231","author":"Craig","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib34","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.3109\/03639049009058544","article-title":"Polyethylene glycols and drug release","volume":"16","author":"Craig","year":"1990","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jctb.5010020901","article-title":"Ideal copolymers and the second order transition of synthetic rubbers 1. Non-crystalline co-polymers","volume":"2","author":"Gordon","year":"1952","journal-title":"J. Appl. Chem."},{"key":"10.1016\/j.ejpb.2008.09.001_bib36","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1023\/A:1011983606606","article-title":"Phase behavior of binary and ternary amorphous mixtures containing indomethacin, citric acid and PVP","volume":"15","author":"Lu","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2008.09.001_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-5173(97)00401-8","article-title":"Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30","volume":"164","author":"Van den Mooter","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib38","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1023\/A:1018906132279","article-title":"Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinylacetate) in relation to indomethacin crystallization","volume":"14","author":"Matsumoto","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2008.09.001_bib39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/03639040500215958","article-title":"Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions","volume":"31","author":"Karavas","year":"2005","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijpharm.2003.11.014","article-title":"Characterization of curcumin-PVP solid dispersion obtained by spray drying","volume":"271","author":"Paradkar","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5173(94)00195-B","article-title":"Preformulation study of etoposide. II: increased solubility and dissolution rate by solid\u2013solid dispersion","volume":"113","author":"Shah","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0378-5173(95)04245-8","article-title":"Effect of particle size on the available surface area of nifedipine from nifedipine-polyethylene glycol 600 solid dispersions","volume":"127","author":"Lin","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1248\/yakushi.126.657","article-title":"Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000","volume":"126","author":"Vijaya Kumar","year":"2006","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ejpb.2008.09.001_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-5173(98)00296-8","article-title":"Investigation of formulation approaches to improve the dissolution of SB-210661, a poorly water soluble 5-lipoxygenase inhibitor","volume":"176","author":"Perng","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10837450601166510","article-title":"Physicochemical characterization, dissolution study of solid dispersions of lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30, Pharm","volume":"12","author":"Patel","year":"2007","journal-title":"Dev. Technol."},{"key":"10.1016\/j.ejpb.2008.09.001_bib46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jps.20805","article-title":"Effect of moisture and pressure on tablet compaction studied with FTIR spectroscopic imaging","volume":"96","author":"Elkhider","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2008.09.001_bib47","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1021\/mp7000796","article-title":"Molecular and thermodynamic aspects of solubility advantage from solid dispersions","volume":"4","author":"Bansal","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1081\/DDC-100102169","article-title":"Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions","volume":"25","author":"Mura","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib49","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1023\/A:1018985110956","article-title":"Solid-state characterization of amorphous sodium indomethacin relative to its free acid","volume":"16","author":"Tong","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2008.09.001_bib50","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1023\/A:1015310213887","article-title":"Influence of alkali metal counterions on the glass transition temperature of amorphous indomethacin salts","volume":"19","author":"Tong","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2008.09.001_bib51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-5173(98)00150-1","article-title":"Dissolution improvement of RS-8350 by the solid dispersion prepared by the solvent method","volume":"170","author":"Usui","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.09.001_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2008.04.001","article-title":"Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release","volume":"129","author":"Tran","year":"2008","journal-title":"J. Control. Rel."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641108003408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641108003408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T11:20:23Z","timestamp":1545736823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641108003408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0939641108003408"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2008.09.001","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}